Piedmont Investment Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-23,321
Closed -$477K 1144
2019
Q1
$477K Buy
+23,321
New +$405K 0.02% 552
2018
Q3
Sell
-972
Closed -$13K 1825
2018
Q2
$13K Buy
+972
New +$10.7K ﹤0.01% 1742

Other funds holding NEO

Piedmont Investment Advisors's NEO Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 23,321 shares — an estimated $477K sold.

Piedmont Investment Advisors first reported a position in NEO in Q2 2018 and held it in 2 quarters. The position peaked at $477K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 23,321 NeoGenomics shares in Q2 2019, an estimated $477K.
  • Piedmont Investment Advisors first reported a position in NeoGenomics in Q2 2018 and held it in 2 quarters.
  • Piedmont Investment Advisors's NeoGenomics position peaked at $477K in Q1 2019.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.